| |
|
| |
/-122.40836334,37.78171539,13,0,0/550x200?access_token=pk.eyJ1IjoiZ2FyeXNndWlkZSIsImEiOiJjamtobmRiYmgwb3gwM3F1a2o2Mmd0YWw3In0.DinA62CR3-OKtf3axa5O7Q)
|
| |
| DETAILS |
|
This event strategically timed to immediately precede biotech's JPMorgan conference promises to be an exciting & engaging occasion, marking the beginning of another successful year.
Building on the momentum of 2025's inaugural event with over 180 attendees, 2026's gathering will feature an array of activities designed to foster collaboration, innovation, & team spirit. Attendees can look forward to inspiring speakers, informative panel discussions, interactive breakout sessions, & opportunities for networking with peers across pharmaceutical & medical device industries.
Benefits of RAPS-SF Kick Off Event
Network with regulatory & quality professionals with allies
Get ready for Year 2026 with the right mindset & latest info
Foster collaboration & education
Increase visibility
Agenda:
5:30-6:00 pm Registration/Networking/Meet Sponsors
6:00-6:15 pm RAPS San Francisco Chapter/Sponsor Announcements
6:15-6:45pm Plenary speech Daniel Kraft, MD Founder & Chair NextMed Health
6:45-7:45 pm Panel discussion topics:
Panel 1: Reflecting Rapid Regulatory Changes in 2025 & What to Expect in 2026
Panel 2: Leading with Impact: Elevating Your Regulatory Voice & Partnering with Allies
7:45-9:00 pm Vendor show/Networking
8:00-8:30 pm Concurrent breakout sessions
Regulatory Innovation
Career Circle (Meet recruiters/Mentors)
Get ready for Inspection
Continued Education
9:00pm Close
Speakers
Leslie Cort
Daniel Kraft
Founder & Chair, NextMed Health
Daniel Kraft is a Stanford & Harvard-trained physician-scientist, inventor, entrepreneur, & innovator. With over 25 years of experience in clinical practice, biomedical research & healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008, & in 2011 founded NextMed Health (previously called Exponential Medicine) a program & community that explores convergent, rapidly developing technologies & their potential in biomedicine & healthcare. He serves as Chair of the XPRIZE Pandemic & Health Alliance.
Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship & is member of the Kauffman Fellows Society. He is a managing partner with Continuum Health Ventures which is focused on funding early stage health tech companies enabling the democratization of health & improved healthspan for all.
Leslie Cort
Keiko Oishi
President & COO, CMIC HOLDINGS Co.,
Since joining CMIC in 1996 as Manager of Strategy Development, Ms. Oishi has led International Business Development across Japan & Asia Pacific, which brings in foreign pharma & biotech companies interested in drug development in Japan & Asia to start their regulatory & clinical activities in the region. She is currently the President & COO of CMIC HOLDINGS Co.,., responsible for group-wide business execution, by overseeing & managing Clinical & Non-clinical CRO (Contract Research Organization), CDMO (Contract Development & Manufacturing Organization), SMO (Site Management Organization) & Marketing Solution (Contract Sales Organization).
Stephanie Seidel
Barbara Troupin, MD, MBA
Fractional Chief Medical Officer
Barbara Troupin is a fractional Chief Medical Officer working for several early-stage biotech, therapeutics & digital health companies. She works to guide teams on portfolio strategy, clinical development, regulatory planning & engagement, fundraising, & company growth. She also sits as an Independent Director on the Board of Equillium Bio (NASDAQ: EQ), & ProSciento, a private-equity backed CRO. Over her 20+ years as a life science executive, her roles have spanned Clinical, Medical, Regulatory, Operations & Strategy functional areas, working in both private & public companies. She holds an MD from the University of Pennsylvania & an MBA from the Wharton School of Business. She is broadly curious; an avid connector & values relationships where mutual learning & growth occur.
Stephanie Seidel
June-Mei Han
Chief, Drug & Medical Device Compliance & Enforcement Section
Food & Drug Branch California Department of Public Health
June graduated from UC Berkeley with a degree in Molecular & Cell Biology. She has worked for the California Department of Public Health, Food & Drug Branch (FDB), for over 22 years. She started in the branch's food safety program & has spent the last 18 years in pharmaceutical & medical device regulation & enforcement. June is currently the chief of FDB's Drug & Medical Device Compliance & Enforcement Section.
Stephanie Seidel
Kevin Holochwost
Technical Director & Product Assessor, SGS
Kevin Holochwost has worked in the regulatory industry as a member of notified bodies for a decade & has worked in the medical device field designing software & hardware systems for twenty years. Before his working with medical devices he worked as a physicist & statistician.
Stephanie Seidel
Yoshiko Stowell, PhD RAC
RAPS-SF Chapter Chair, Incoming Board Member
|
|
|
|
|
|
|
|
